HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wojciech Danysz Selected Research

SB-699551-A

8/2012Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wojciech Danysz Research Topics

Disease

11Dyskinesias (Dyskinesia)
01/2017 - 04/2006
10Parkinson Disease (Parkinson's Disease)
01/2021 - 04/2006
8Pain (Aches)
01/2021 - 02/2003
8Alzheimer Disease (Alzheimer's Disease)
10/2013 - 07/2002
7Schizophrenia (Dementia Praecox)
08/2012 - 07/2002
6Seizures (Absence Seizure)
11/2018 - 04/2003
6Hyperalgesia
06/2016 - 08/2004
4Dementia (Dementias)
12/2012 - 07/2002
4Cognitive Dysfunction
04/2011 - 07/2002
4Stroke (Strokes)
01/2007 - 01/2002
3Chronic Pain
06/2016 - 08/2004
3Alcoholism (Alcohol Abuse)
11/2011 - 10/2004
3Catalepsy
03/2010 - 04/2006
2Central Nervous System Diseases (CNS Diseases)
11/2018 - 04/2011
2Neuralgia (Stump Neuralgia)
06/2016 - 09/2005
2Inflammation (Inflammations)
06/2016 - 09/2003
2Ischemia
01/2015 - 05/2006
2Brain Ischemia (Cerebral Ischemia)
01/2015 - 05/2006
2Hypoxia (Hypoxemia)
01/2015 - 05/2006
2Memory Disorders (Memory Loss)
12/2012 - 09/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2006 - 01/2005
2Partial Epilepsies (Epilepsy, Partial)
06/2006 - 04/2003
1Spinal Cord Injuries (Spinal Cord Injury)
01/2021
1Human Influenza (Influenza)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Calciphylaxis
01/2020
1Fragile X Syndrome (Martin Bell Syndrome)
11/2018
1Substance-Related Disorders (Drug Abuse)
01/2017
1Hypothermia
01/2017
1Body Weight (Weight, Body)
01/2017
1Hypersensitivity (Allergy)
06/2016
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2015

Drug/Important Bio-Agent (IBA)

12Levodopa (L Dopa)FDA LinkGeneric
11/2018 - 04/2006
11N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2013 - 04/2003
9Memantine (Namenda)FDA Link
10/2013 - 09/2003
8Glutamic Acid (Glutamate)FDA Link
11/2018 - 09/2003
8Pharmaceutical PreparationsIBA
11/2018 - 01/2002
7Formaldehyde (Formol)FDA Link
12/2012 - 02/2003
6Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2011 - 04/2006
5neramexaneIBA
10/2009 - 03/2002
5pyridineIBA
12/2008 - 04/2006
4N-Methylaspartate (NMDA)IBA
11/2008 - 08/2004
3Dopamine (Intropin)FDA LinkGeneric
06/2015 - 04/2007
3fenobamIBA
01/2015 - 08/2009
3S- (4- fluorophenyl)- (3- (3- (4- fluorophenyl)- (1,2,4)- oxadiazol- 5- yl)piperidin- 1- yl)methanoneIBA
01/2015 - 11/2009
3Amyloid beta-PeptidesIBA
12/2011 - 09/2003
3Ethanol (Ethyl Alcohol)IBA
11/2011 - 10/2004
3eglumetadIBA
11/2009 - 09/2005
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2008 - 04/2003
3metabotropic glutamate receptor type 1IBA
07/2007 - 04/2006
3Glutamate Receptors (Glutamate Receptor)IBA
04/2007 - 08/2004
3methanesulfonic acid (methanesulfonate)IBA
01/2007 - 04/2006
3Opioid Analgesics (Opioids)IBA
11/2005 - 08/2004
2Amantadine (Aman)FDA LinkGeneric
01/2021 - 01/2021
2Metabotropic Glutamate 5 ReceptorIBA
11/2018 - 01/2015
2Freund's AdjuvantIBA
06/2016 - 07/2007
2Scopolamine (Hyoscine)FDA Link
12/2012 - 09/2011
2Peptides (Polypeptides)IBA
09/2012 - 12/2011
2Antipsychotic Agents (Antipsychotics)IBA
08/2012 - 11/2009
2LigandsIBA
08/2012 - 04/2006
2Haloperidol (Haldol)FDA LinkGeneric
03/2010 - 04/2006
2HexanesIBA
11/2009 - 02/2009
2metabotropic glutamate receptor 2IBA
02/2009 - 09/2005
2MRZ 2-576IBA
01/2008 - 01/2002
2AcidsIBA
04/2006 - 07/2002
2Morphine (MS Contin)FDA LinkGeneric
11/2005 - 09/2005
1Antiviral Agents (Antivirals)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1sodium thiosulfateFDA Link
01/2020
1Chelating AgentsIBA
01/2020
1mavoglurantIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1MRZ-8456IBA
11/2018
1eltoprazineIBA
01/2017
14-amino-3-phenylbutyric acid (phenibut)IBA
06/2016
1Gabapentin (Neurontin)FDA LinkGeneric
06/2016
1Calcium Channels (Calcium Channel)IBA
06/2016
1Oxidopamine (6 Hydroxydopamine)IBA
09/2015
1Methylphenidate (Ritalin)FDA LinkGeneric
09/2015
1Methenamine (Hexamine)IBA
09/2015
1sarizotanIBA
09/2015
12- (2- oxo- 4- phenylpyrrolidin- 1- yl)acetamideIBA
06/2015
1Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2013
1Nootropic Agents (Nootropics)IBA
12/2012
1Cholinergic Agents (Cholinergics)IBA
12/2012
1Carboxylic AcidsIBA
12/2012
1gamma-Aminobutyric Acid (GABA)IBA
12/2012
13'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA
12/2012
1L 838,417IBA
12/2012
1Amyloid (Amyloid Fibrils)IBA
09/2012
1serotonin 5 receptorIBA
08/2012
1N- (2,6- dimethoxybenzyl)- N'- (4- (4- fluorophenyl)thiazol- 2- yl)guanidineIBA
08/2012
1SB-699551-AIBA
08/2012
1Antidepressive Agents (Antidepressants)IBA
08/2012
1Phencyclidine (Angel Dust)IBA
08/2012
1Amphetamine (Amfetamine)FDA LinkGeneric
08/2012
1Anti-Anxiety Agents (Anxiolytics)IBA
08/2012
1Guanidine (Guanidine Nitrate)FDA Link
08/2012

Therapy/Procedure

4Therapeutics
10/2013 - 07/2002
3Ligation
12/2012 - 08/2004